N MAT is a high-quality, secure "Computer Adaptive Test" in which a candidate's ability is estimated successively based on the responses to the questions administered, which are tailored to the ...

and community testing, which increased 38%. Adaptive announced a strategic partnership with NeoGenomics to cross-promote clonoSEQ and Neo’s COMPASS and CHART services, aiming to expand its ...

Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...